Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout that ...

Key Points Net revenue (GAAP) dropped 18.1% year-over-year in Q2 2025, as reimbursement pressure continued to impact results despite increased unit sales for DEXTENZA. Research and development ...

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...

One United Properties (BVB: ONE), the leading Romanian green developer of residential, mixed-use, and office properties, recorded total sales and pre-sales of EUR 95.4 million in H1 2025, ...

Having built a strong foothold in Rajasthan with landmark developments and expanding its footprint into the Delhi-NCR market, ...

El Pollo Loco is working through a choppy sales environment, with guests feeling limited on what they can spend. Even with ...

Dubai’s off-plan branded residences are taking centre stage in the luxury property market, accounting for 83 per cent of ...

Pipeline Regulatory Progress -- Two risk-adjusted product launches (AMP-002 and AMP-015) are included in the flat full-year ...

President Donald Trump's administration and its allies have pushed aggressively for drilling, mining and logging in Alaska.

Pipedrive’s new tool helps small business sales teams prioritize leads, automate prospecting, and focus on the most promising ...

DLF reports an 18% rise in Q1 FY26 PAT, driven by record sales of Rs 11,425 crore. Revenue nearly doubles to Rs 2,716 crore ...

Q2 2025 Management View President and CEO Jeffrey M. Dayno reaffirmed Harmony's position as a "profitable, self-funding biotech company with an innovative late-stage pipeline poised to deliver ...